Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2/3
×
INDUSTRY
×
Oropharyngeal Neoplasms
×
Clear all
Filters
3
NCT06295731
2025-11-17
HexAgon-HN
Inhibrx Biosciences, Inc
Phase 2/3
Recruiting
410 enrolled
NCT04648020
2023-05-31
VOICE
Monopar Therapeutics
Phase 2/3
Terminated
190 enrolled